Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Gilead Expands R&D In Canada

by Rick Mullin
November 19, 2012 | A version of this story appeared in Volume 90, Issue 47

Gilead Sciences has agreed to purchase and develop a 10-acre plot in Edmonton, Alberta. The company plans to build a 45,000-sq-ft R&D facility on the site, which is across the street from its existing R&D operation in Edmonton. The new building will house at least 80 process chemistry and analytical development scientists. The company, which currently has a staff of 220 in Edmonton, plans to hire 50 new researchers. Gilead purchased its current Edmonton site from Degussa, now Evonik Industries, for $146 million in 2006.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.